Hints and tips:
Related Special Reports
...The company specialises in oncology, but its only approved product is in infectious diseases....
...US-based hedge fund Shah Capital wrote to the Novavax board on Monday to push for the instalment of two new independent board directors....
...On Tuesday, Shanahan vowed to fix chronic disease within “weeks, not years” of being elected....
...The company is trying to expand the use of its immunology drug Vyvgart to different diseases. It is used against a rare chronic immune disorder called myasthenia gravis, which causes muscle weakness....
...The fund was set up by the government in partnership with industry and the charity Alzheimer’s Research UK to invest in innovative approaches to tackling the disease....
...Need to know: business Novo Nordisk announced a €1bn deal for a German biotech developing therapies to treat heart disease, as the Danish group seeks to branch out from its blockbuster diabetes and weight...
...From climate change to chronic under-investment, these problems will not be resolved with a change in the season....
...The regulator will monitor Amgen’s contracts involving Horizon’s drugs Tepezza, for thyroid eye disease, and Krystexxa, for chronic gout....
...Long Covid: With millions unwell, scientists fear that the condition’s range of symptoms and link to chronic diseases will have a lasting impact on health systems....
...Rising public expectations and the changing burden of disease create opportunities for patients to be much more actively involved in their own care....
...Some medical research groups, such as IGeneX, think that the symptoms seem “similar to chronic Lyme disease, a condition that affects thousands of people a year”....
...He warned that it could cut returns on drugs for cancer and rare diseases, and said AstraZeneca is already changing how it allocates research and development funds because of the new law....
...or credit crossover funds or systematic quant funds at that at that time,” he says....
...The failure to legislate adequately on food and drink industries is partly responsible for the epidemic of preventable, complex, chronic diseases overwhelming the NHS and social care....
...As well as Alzheimer’s disease and obesity, it also wants to expand its drug pipeline in oncology and develop treatments for underserved illnesses such as chronic pain, he said....
...But its care industry is still struggling with chronic staff shortages. Nearly 690,000 additional nurses will be required by 2040 to meet demand, says the health ministry....
...“This is much better,” says the 54-year-old tomato farmer, who suffers from chronic kidney disease. Previously, his treatment was “very cumbersome”....
...“We realised that a challenge in tackling liver disease, as in a lot of chronic diseases, is the lack of good models,” said Jack O’Meara, Ochre chief executive....
...But it has the funds. Merck’s market capitalisation is $300bn and it has more than $13bn in cash....
...David Ricks, Eli Lilly’s chief executive, said under a draft plan to cut market exclusivity protection from 10 to eight years, it might not be worth the industry pursuing treatments for chronic diseases...
...A study led by Natalia Rebolledo, a researcher at the Center for Research in Food Environments and Prevention of Chronic Diseases Associated with Nutrition in Chile, found that after the country introduced...
...Many drugmakers are tempted by China’s large, ageing population, which is increasingly affected by chronic diseases partly caused by smoking, pollution and more westernised diets....
...More initiatives like the Dementia Discovery Fund, a public-private partnership based in the UK, are needed....
...Horizon’s assets, which include treatments for chronic gout and neuromyelitis optica, a disease affecting the central nervous system, had also attracted interest from Johnson & Johnson and Sanofi....
...The biotech sector has been particularly hard hit by the IPO freeze, as early-stage companies rely on equity sales to fund long and expensive drug developments....
International Edition